Comparison of microRNA Expression Profile in Chronic Myeloid Leukemia Patients Newly Diagnosed and Treated by Allogeneic Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Comparison of microRNA Expression Profile in Chronic Myeloid Leukemia Patients Newly Diagnosed and Treated by Allogeneic Hematopoietic Stem Cell Transplantation

Published:2020-09-04 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Martins Juliana Ravelli Baldassarre,Moraes Leonardo Nazario de,Cury Sarah Santiloni,Dadalto Juliane,Capannacci Juliana,Carvalho Robson Francisco,Nogueira Célia Regina,Hokama Newton Key,Hokama Paula de Oliveira Montandon

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference70 articles.

1. Analysis of microRNA and gene networks in human chronic myelogenous leukemia;Wang;Mol Med Rep.,2016

2. Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring;Jabbour;Am J Hematol.,2018

3. Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells;Spagnuolo;Haematologica.,2019

4. A critical history of chronic myeloid leukemia;Baccarani;Mediterr J Hematol Infect Dis.,2014

5. Chronic myeloid leukemia: a historical perspective;Goldman;Semin Hematology.,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Insights into Structure, Regulation, and Targeting of ABL Kinases in Human Leukemia;International Journal of Molecular Sciences;2024-03-14

2. Role of miRNAs to control the progression of Chronic Myeloid Leukemia by their expression levels;Medical Oncology;2024-01-12

3. Enabling biomedical technologies for chronic myelogenous leukemia (CML) biomarkers detection;Biomicrofluidics;2024-01-01

4. Integrated Multi-omics Analyses Identify CDCA5 as a Novel Biomarker Associated with Alternative Splicing, Tumor Microenvironment, and Cell Proliferation in Colon Cancer Via Pan-cancer Analysis;Journal of Cancer;2024

5. Identification of multivariable microRNA and clinical biomarker panels to predict imatinib response in chronic myeloid leukemia at diagnosis;Leukemia;2023-10-17